Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 53 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung CancerStatus unknownNCT02151721Phase 1
- A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung AdenocarcinomaStatus unknownNCT02146118Phase 2
- Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung CancerStatus unknownNCT02139579Phase 2
- A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung CancerCompletedNCT02136355Not applicable
- Healthy Directions After Lung Surgery PilotCompletedNCT02135211Not applicable
- Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung CancerStatus unknownNCT02134990Phase 2
- Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV InfectionTerminatedNCT02134886Phase 1
- Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung CancerCompletedNCT02132325Not applicable
- Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerWithdrawnNCT02126527Phase 1
- Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)CompletedNCT02118415Phase 2
- SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC PatientsCompletedNCT02117167Phase 2
- Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer PatientsCompletedNCT02113852
- A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT02113813Phase 1
- Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLCWithdrawnNCT02109653Phase 2
- Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.CompletedNCT02109549
- A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic AlterationsTerminatedNCT02109016Phase 2
- Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyWithdrawnNCT02106559Not applicable
- Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerCompletedNCT02106546Phase 3
- Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor MutationTerminatedNCT02095782Phase 2
- MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).CompletedNCT02088112Phase 1
- A Phase I Dose Escalation Study of Erlotinib in Combination With TheophyllineTerminatedNCT02080078Phase 1
- The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）Status unknownNCT02076477Phase 3
- MRI Optimization Study in Stage III NSCLCStatus unknownNCT02076282
- Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung CancerStatus unknownNCT02075957
- Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer PatientStatus unknownNCT02069418Phase 2
- Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKIStatus unknownNCT02066870Phase 1
- Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) MutationStatus unknownNCT02066038Phase 2
- Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLCCompletedNCT02064491Phase 2
- Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic InsufficiencyStatus unknownNCT02062515Phase 2
- Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLCWithdrawnNCT02059967Phase 1
- Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung CancerWithdrawnNCT02059889Not applicable
- Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT02058433Phase 3
- Neoadjuvant Finasteride for Patients With Non-small Cell Lung CancerTerminatedNCT02055170Phase 2
- Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard ChemotherapyStatus unknownNCT02055144
- Treating NSCLC Minimal Stage IV With Curative IntentTerminatedNCT02054819Phase 2
- Intrapleural Bevacizumab Injection for Malignant Effusion in Lung CancerCompletedNCT02054052Phase 2
- Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung CancerCompletedNCT02053285
- Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)CompletedNCT02043002Not applicable
- A Prospective Epidemiologic Study of ALK-Positive NSCLC in ChinaCompletedNCT02042105
- Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsStatus unknownNCT02041468
- Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC PatientsCompletedNCT02040064Phase 1
- State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of PatientsCompletedNCT02038413
- Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLCStatus unknownNCT02037997Phase 2
- Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung caStatus unknownNCT02036359Phase 2
- PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First ChemotherapyStatus unknownNCT02035683Not applicable
- A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung CancerWithdrawnNCT02034097Phase 2
- A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung CancerCompletedNCT02031744Phase 3
- Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung CancerStatus unknownNCT02031601Phase 4
- RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVERCompletedNCT02029729Phase 1
- Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinTerminatedNCT02029690Phase 1
- To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT02029209Phase 2/3
- High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable DiseaseStatus unknownNCT02027090Phase 2
- Selumetinib in Combination With Gefitinib in NSCLC PatientsCompletedNCT02025114Phase 1/2
- PALBOCICLIB + PD-0325901 for NSCLC & Solid TumorsCompletedNCT02022982Phase 1
- Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung CancerTerminatedNCT02018523Phase 1
- Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing ChemoradiationWithdrawnNCT02017925Not applicable
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung CancerStatus unknownNCT02016209Phase 2
- A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerCompletedNCT02015416Phase 1
- Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWithdrawnNCT02014545Phase 2
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsCompletedNCT02014337Phase 1
- A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02013219Phase 1
- Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.TerminatedNCT02012231Phase 1
- Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC PatientsCompletedNCT02010047Not applicable
- Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerCompletedNCT02009436Phase 1
- Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)Status unknownNCT02006043Phase 2
- Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLCStatus unknownNCT02005120Phase 2
- Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction ChemotherapyTerminatedNCT02004184Phase 3
- Genotyping of Non-small Cell Lung CancerStatus unknownNCT02002117
- Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical TrialTerminatedNCT02002052Phase 2
- Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR MutationStatus unknownNCT02001896Phase 3
- Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠBStatus unknownNCT02001168Phase 3
- A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT02000947Phase 1
- Impacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsCompletedNCT01999881Not applicable
- Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid TumorsCompletedNCT01999738Phase 1
- Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung CancerCompletedNCT01999673Phase 3
- Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung CancerCompletedNCT01998126Phase 1
- Continuation of TKI With or Without Chemotherapy Beyond Gradual ProgressionStatus unknownNCT01998061Phase 2
- Metformin in Stage IV Lung AdenocarcinomaTerminatedNCT01997775Phase 2
- A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerCompletedNCT01995188Phase 1
- Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung CancerActive, not recruitingNCT01993810Phase 3
- Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)CompletedNCT01991418
- Study of Use of CTC in NSCLCStatus unknownNCT01990651
- Nodal Upstaging in VATS Anatomical Resections for NSCLCStatus unknownNCT01985659
- Correlation Research of Thioredoxin Reductase in Lung CancerCompletedNCT01985113
- Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer PatientsStatus unknownNCT01980472Phase 2
- Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung CancerCompletedNCT01980212
- Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High ExpressionStatus unknownNCT01977209Phase 3
- Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsWithdrawnNCT01971489Phase 1
- Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer PatientsCompletedNCT01968941Phase 3
- An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 RearrangementCompletedNCT01964157Phase 2
- Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLCCompletedNCT01963351
- Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung CancerCompletedNCT01958372Phase 1
- Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung CancerCompletedNCT01956331
- Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant NsclcStatus unknownNCT01955421Phase 2
- Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01951755
- Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung CancerCompletedNCT01951690Phase 2
- Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT01951469Phase 3
- Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung CancerCompletedNCT01950156Phase 1/2
- Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung CancerCompletedNCT01949701Phase 1/2
- Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase InhibitorCompletedNCT01947868